Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.66 |
| ▸ | MGAM | O43451 | 5/20 | 0.62 |
| ▸ | GAA | P10253 | 4/20 | 0.61 |
| ▸ | SI | P14410 | 4/20 | 0.61 |
| ▸ | MGAM2 | Q2M2H8 | 4/20 | 0.61 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.61 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.60 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.59 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.59 |
| ▸ | PTGES | O14684 | 1/20 | 0.58 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Macarangin SCHEMBL30234138 | 1.00 | ABCG2 (1.00) | ABCG2PTPN1MGAMGAASI | |
| SCHEMBL6822263 | 0.91 | ABCG2 (0.84) | ABCG2PTPN1MGAMGAASI | |
| SCHEMBL6822261 | 0.91 | ABCG2 (0.84) | ABCG2PTPN1MGAMGAASI | |
| Licoflavonol SCHEMBL29392785 | 0.91 | ABCG2 (0.82) | ABCG2PTPN1MGAMGAASI | |
| Licoflavonol SCHEMBL8050093 | 0.91 | ABCG2 (0.82) | ABCG2PTPN1MGAMGAASI | |
| SCHEMBL18037681 | 0.85 | MGAM (0.75) | ABCG2PTPN1MGAMGAASI | |
| SCHEMBL18037680 | 0.85 | MGAM (0.75) | ABCG2PTPN1MGAMGAASI | |
| SCHEMBL3336163 | 0.84 | ALOX5 (0.77) | ABCG2PTPN1MGAMGAASI | |
| SCHEMBL3336171 | 0.84 | ALOX5 (0.77) | ABCG2PTPN1MGAMGAASI | |
| SCHEMBL29833892 | 0.84 | ALOX5 (0.77) | ABCG2PTPN1MGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12102653-B2 | Ligand regulated protein-protein interaction system | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2024-10-01 | — | — | US | disclosed |
| US-20240000841-A1 | LIGAND REGULATED PROTEIN-PROTEIN INTERACTION SYSTEM | ST ANNA KINDERKREBSFORSCHUNG (AT) | 2024-01-04 | — | — | US | disclosed |
| US-11844813-B2 | Ligand regulated protein-protein interaction system | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2023-12-19 | — | — | US | disclosed |
| US-11795127-B2 | Processes for the preparation of ortho-allylated hydroxy aryl compounds | MCMASTER UNIVERSITY (CA) | 2023-10-24 | — | — | US | disclosed |
| US-11795127-B2 | Processes for the preparation of ortho-allylated hydroxy aryl compounds | MCMASTER UNIVERSITY (CA) | 2023-10-24 | — | — | US | disclosed |
| US-20230113567-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | MCMASTER UNIVERSITY (CA) | 2023-04-13 | — | — | US | disclosed |
| US-20220041687-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2022-02-10 | — | — | US | disclosed |
| US-20210386781-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | UNIVERSITÄT FÜR BODENKULTUR WIEN (AT) | 2021-12-16 | — | — | US | disclosed |
| US-20210380513-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | MCMASTER UNIVERSITY (CA) | 2021-12-09 | — | — | US | disclosed |
| WO-2021237371-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | MCMASTER UNIVERSITY (CA) | 2021-12-02 | — | — | WO | disclosed |
| EP-3860643-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | St. Anna Kinderkrebsforschung (AT) | 2021-08-11 | — | — | EP | disclosed |
| EP-3860642-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | St. Anna Kinderkrebsforschung (AT) | 2021-08-11 | — | — | EP | disclosed |
| US-20200390813-A1 | LIGAND REGULATED PROTEIN-PROTEIN INTERACTION SYSTEM | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2020-12-17 | — | — | US | disclosed |
| EP-3728306-A1 | LIGAND REGULATED PROTEIN-PROTEIN INTERACTION SYSTEM | St. Anna Kinderkrebsforschung (AT) | 2020-10-28 | — | — | EP | disclosed |
| WO-2020070290-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2020-04-09 | — | — | WO | disclosed |
| WO-2020070289-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2020-04-09 | — | — | WO | disclosed |
| EP-3502130-A1 | LIGAND REGULATED PROTEIN-PROTEIN INTERACTION SYSTEM | St. Anna Kinderkrebsforschung (AT) | 2019-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230113567-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | ADH1A, ADH1C, AHR | ABCG2 1860/4885PTPN1 395/4885MGAM 3381/4885 |
| US-20210380513-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | ADH1A, ADH1C, AHR | ABCG2 1860/4885PTPN1 395/4885MGAM 3381/4885 |
| US-11795127-B2 | Processes for the preparation of ortho-allylated hydroxy aryl compounds | ADH1A, ADH1C, AHR | ABCG2 1860/4885PTPN1 395/4885MGAM 3381/4885 |
| US-20220041687-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | CARS1, CD74, HAVCR2 | ABCG2 3223/4885PTPN1 1563/4885MGAM 2470/4885 |
| US-20210386781-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | CD74, HAVCR2, CD2BP2 | ABCG2 4376/4885PTPN1 1140/4885MGAM 1901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.